Skip to main content
Home
  • English
  • Français
  • Login
  • About Us
    • About Us
    • CASW Awards
      • Glenn Drover National Award for Outstanding Service
      • CASW Distinguished Service Award
      • Application - Glenn Drover National Award for Outstanding Service
    • CASW Structure
      • Board Members
      • Staff
      • IFSW
        • Sustainability Workbook
      • Partner Organizations
    • CASW History
      • Presidents and Executive Directors
      • President Stories
      • CASW Remembers
    • Social Work in Canada
      • What is Social Work?
      • What Social Workers Do
      • Regulation, Association & Education
        • Regulatory Bodies
        • What is Regulation?
      • How do I become a Social Worker?
      • Looking for Social Work Services
    • Annual Report
  • Members
    • Login
    • Am I a Member?
    • Member Benefits
    • Become a Member or Renew
    • Member's Portal
    • Private Practice Portal
  • Continuing Education
    • Professional Development
    • CASW Webinars
    • Search CASW Webinar Archive
    • Social Work in Primary Care Modules
    • TRAIN Learning Network
    • Social Work Online CE Institute
    • Additional Continuing Education Opportunities
  • Internationally Educated
    • Application Procedure
    • FAQ
  • Advocacy
    • CASW Social Policy Principles
    • Policy & Position Statements
    • Coalitions & Allies
    • Reports
  • Resources
    • CASW Code of Ethics, Values and Guiding Principles 2024
      • Historical Content and Development
    • CASW Social Work Scope of Practice
    • Canadian Social Work Journal
    • Practice Resources
    • Virtual Counselling Resources
    • CASW Reconciliation Hub
    • Family and Intimate Partner Violence Resources
    • The Journal of Social Work Values and Ethics
    • Social Work and Employee Benefit Plans
  • News
    • News
    • Events
    • Job Listings

Statement on the Decriminalization of Personal Use of Psychoactive Substances

  1. Home
  2. News

For Immediate Release

 

OTTAWA

July 10, 2020

Statement on the Decriminalization of Personal Use of Psychoactive Substances

 

Ottawa, On -  July 10, 2020 - The Canadian Association of Social Workers (CASW) strongly supports and applauds the Canadian Association of Chiefs of Police (CACP) for its leadership in recommending, to the Government of Canada, decriminalizing the possession of small amounts of illegal drugs for personal consumption.

 

“The recognition of CACP that substance use is a public health issue and should be treated as such is the leadership needed for the Government of Canada to finally make a full paradigm shift to save lives,” states CASW President, Joan Davis-Whelan. “With the COVID-19 pandemic heightening the opioid crisis, it is imperative the government act swiftly to decriminalize illegal drugs and redirect resources to support harm reduction and recovery.”

 

In 2018, CASW released a position statement outlining the need for a public health approach to substance use, championed by decriminalizing the personal use of psychoactive substances. 

 

Beyond decriminalization, CASW encourages the Government of Canada to uphold its commitment to eliminate mandatory minimums specific to drug possession. The opioid crisis demonstrates that criminalization does not reduce illegal psychoactive substance use and worsens health outcomes across the country. 

 

The alternative to criminalization is a public health approach based on the principles of social justice, human rights, and equity, accompanied by equitable access to evidence-informed treatment and addressing the underlying determinants of health.

 

-30-

For further information:

Fred Phelps, Executive Director

Tel: 613-729-6668

e-mail: fred.phelps@casw-acts.ca

 

 

Attachment: 
PDF icon Statement-on-the-Decriminalization-of-Personal-Use-of-Psychoactive-Substances.-Bilingual.pdf
  • Français

Canadian Association of Social Workers - Association canadienne des travailleuses et travailleurs sociaux
  Facebook    613-729-6668   casw@casw-acts.ca     Youtube     LinkedIn    Instagram
  • Contact us
  • Copyright Notice
  • Disclaimer
  • Privacy policy